Michael Clearfield
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 15
- Surgery top 0.2%
- Lipoproteins and Cardiovascular Health 38
- Cancer Research top 1%
- Economics and Econometrics top 0.5%
- Health Systems, Economic Evaluations, Quality of Life 13
- Pharmaceutical Economics and Policy 4
-
- Adipokines, Inflammation, and Metabolic Diseases 6
-
- Atherosclerosis and Cardiovascular Diseases 4
-
- Pharmacology and Obesity Treatment 3
-
- Health and Medical Research Impacts 3
- Co-authors
- Antonio M. GottoJohn R. DownsStephen E. WeisPolly A. BeereDeborah R. ShapiroEdwin J. WhitneyAlexandra LangendörferPaul M. Ridker
- Journals
- Current Atherosclerosis Reports (10 papers)The American Journal of Cardiology (6 papers)JAMA (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Michael Clearfield
60 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Endocrinology, Diabetes and Metabolism 3.0k
- Surgery 5.9k
- Cardiology and Cardiovascular Medicine 2.2k
- Cancer Research 1.3k
- Economics and Econometrics 1.6k
Countries citing papers authored by Michael Clearfield
This map shows the geographic impact of Michael Clearfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Clearfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Clearfield more than expected).
Fields of papers citing papers by Michael Clearfield
This network shows the impact of papers produced by Michael Clearfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Clearfield. The network helps show where Michael Clearfield may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Clearfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 17 | |
| 2 | 2013 | 282 | |
| 3 | 2010 | 1 | |
| 4 | 2010 | 3 | |
| 5 | 2009 | 6 | |
| 6 | 2009 | 48 | |
| 7 | 2009 | 42 | |
| 8 | 2008 | 6 | |
| 9 | 2007 | 1 | |
| 10 | 2006 | 20 | |
| 11 | Hemodynamic effects of osteopathic manipulative treatment immediately after coronary artery bypass graft surgery. | 2005 | 29 |
| 12 | 2005 | 22 | |
| 13 | 2003 | 4 | |
| 14 | Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Eventsbreakdown → | 2001 | 1239 |
| 15 | 2001 | 76 | |
| 16 | 2000 | 10 | |
| 17 | 2000 | 27 | |
| 18 | Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levelsbreakdown → | 1998 | 4060 |
| 19 | 1997 | 3 | |
| 20 | 1994 | 7 |
About Michael Clearfield
Michael Clearfield is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Anatomy, Economics and Econometrics and Complementary and alternative medicine, having authored 64 papers that have together received 8.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (38 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Pharmaceutical Economics and Policy (4 papers), Pharmacology and Obesity Treatment (3 papers) and Health and Medical Research Impacts (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.0k citations), Surgery (5.9k citations), Cardiology and Cardiovascular Medicine (2.2k citations), Cancer Research (1.3k citations) and Economics and Econometrics (1.6k citations). Michael Clearfield has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Antonio M. Gotto, John R. Downs, Stephen E. Weis, Polly A. Beere, Deborah R. Shapiro, Edwin J. Whitney, Alexandra Langendörfer, Paul M. Ridker, Evan A. Stein and William B. Kruyer. Their work appears in journals such as Current Atherosclerosis Reports, The American Journal of Cardiology, JAMA, Academic Medicine and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.